Financials data is unavailable for this security.
View more
Year on year Shofu Inc grew revenues 10.74% from 31.68bn to 35.08bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 16.61% net income growth from 3.14bn to 3.66bn.
| Gross margin | 59.71% |
|---|---|
| Net profit margin | 11.92% |
| Operating margin | 14.59% |
| Return on assets | 9.48% |
|---|---|
| Return on equity | 11.19% |
| Return on investment | 10.62% |
More ▼
Cash flow in JPYView more
In 2024, Shofu Inc did not generate a significant amount of cash. However, the company earned 3.09bn from its operations for a Cash Flow Margin of 8.80%. In addition the company used 1.30bn on investing activities and also paid 2.10bn in financing cash flows.
| Cash flow per share | 114.79 |
|---|---|
| Price/Cash flow per share | 18.29 |
| Book value per share | 1,168.62 |
|---|---|
| Tangible book value per share | 1,152.87 |
More ▼
Balance sheet in JPYView more
| Current ratio | 5.09 |
|---|---|
| Quick ratio | 2.89 |
| Total debt/total equity | 0.0048 |
|---|---|
| Total debt/total capital | 0.0048 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 31.91% and 17.19%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked above the industry average relative to its peers.
| Div yield(5 year avg) | 1.96% |
|---|---|
| Div growth rate (5 year) | 21.94% |
| Payout ratio (TTM) | 16.70% |
| EPS growth(5 years) | 22.30 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 74.57 |
More ▼
